Standardized definitions of molecular response in chronic myeloid leukemia
The International Randomized Study of Interferon and STI571 (IRIS) demonstrated long-term cytogenetic responses in patients with chronic-phase chronic myeloid leukemia (CML-CP) treated with the tyrosine kinase inhibitor (TKI) imatinib. However, deep molecular responses (MRs), as measured by reductio...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 April 2012
|
| In: |
Leukemia
Year: 2012, Jahrgang: 26, Heft: 10, Pages: 2172-2175 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/leu.2012.104 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/leu.2012.104 Verlag, Volltext: https://www.nature.com/articles/leu2012104 
|
| Verfasserangaben: | N.C.P. Cross, H.E. White, M.C. Müller, G. Saglio, & A. Hochhaus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1582644497 | ||
| 003 | DE-627 | ||
| 005 | 20220815050551.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181107s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2012.104 |2 doi | |
| 035 | |a (DE-627)1582644497 | ||
| 035 | |a (DE-576)512644497 | ||
| 035 | |a (DE-599)BSZ512644497 | ||
| 035 | |a (OCoLC)1341022504 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Cross, Nicholas C. P. |e VerfasserIn |0 (DE-588)114316430X |0 (DE-627)1002558190 |0 (DE-576)494954248 |4 aut | |
| 245 | 1 | 0 | |a Standardized definitions of molecular response in chronic myeloid leukemia |c N.C.P. Cross, H.E. White, M.C. Müller, G. Saglio, & A. Hochhaus |
| 264 | 1 | |c 16 April 2012 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.11.2018 | ||
| 520 | |a The International Randomized Study of Interferon and STI571 (IRIS) demonstrated long-term cytogenetic responses in patients with chronic-phase chronic myeloid leukemia (CML-CP) treated with the tyrosine kinase inhibitor (TKI) imatinib. However, deep molecular responses (MRs), as measured by reductions in BCR-ABL transcript levels below the threshold of major MR, were achieved only by a small proportion of patients. With the advent of the second-generation TKIs nilotinib and dasatinib for the treatment of patients with newly diagnosed CML-CP, the proportion of patients who achieve the deepest levels of MR is likely to increase significantly. With these changes, the potential for patient eligibility in TKI cessations studies is becoming a more widely discussed topic and area for research. These developments highlight the need for robust, standardized and workable definitions of deep MRs. Specifically, it is critical that the measurement of MR is standardized in a manner to withstand both intra- and inter-laboratory variability, as well as new methodological developments. This review summarizes the relevant clinical background and proposes a framework within which standardization of MR can be taken forward. | ||
| 700 | 1 | |a Müller, Martin Christian |d 1972- |e VerfasserIn |0 (DE-588)121360296 |0 (DE-627)705409236 |0 (DE-576)181482819 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 26(2012), 10, Seite 2172-2175 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Standardized definitions of molecular response in chronic myeloid leukemia |
| 773 | 1 | 8 | |g volume:26 |g year:2012 |g number:10 |g pages:2172-2175 |g extent:4 |a Standardized definitions of molecular response in chronic myeloid leukemia |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/leu.2012.104 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/leu2012104 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181107 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 121360296 |a Müller, Martin Christian |m 121360296:Müller, Martin Christian |d 60000 |d 61200 |e 60000PM121360296 |e 61200PM121360296 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 999 | |a KXP-PPN1582644497 |e 3030548740 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["N.C.P. Cross, H.E. White, M.C. Müller, G. Saglio, & A. Hochhaus"]},"origin":[{"dateIssuedDisp":"16 April 2012","dateIssuedKey":"2012"}],"id":{"doi":["10.1038/leu.2012.104"],"eki":["1582644497"]},"physDesc":[{"extent":"4 S."}],"relHost":[{"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"language":["eng"],"recId":"32046699X","note":["Gesehen am 15.03.04"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Standardized definitions of molecular response in chronic myeloid leukemiaLeukemia","part":{"issue":"10","pages":"2172-2175","year":"2012","extent":"4","text":"26(2012), 10, Seite 2172-2175","volume":"26"},"pubHistory":["Nachgewiesen 11.1997 -"],"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-"}],"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"role":"aut","display":"Cross, Nicholas C. P.","roleDisplay":"VerfasserIn","given":"Nicholas C. P.","family":"Cross"},{"family":"Müller","given":"Martin Christian","roleDisplay":"VerfasserIn","display":"Müller, Martin Christian","role":"aut"}],"title":[{"title_sort":"Standardized definitions of molecular response in chronic myeloid leukemia","title":"Standardized definitions of molecular response in chronic myeloid leukemia"}],"note":["Gesehen am 07.11.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1582644497"} | ||
| SRT | |a CROSSNICHOSTANDARDIZ1620 | ||